Martin Shkreli, the pharmaceutical executive arrested Thursday on charges of securities fraud related to a company he previously ran, has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals.
He's being replaced on an interim basis by Ron Tilles, who has been chairman of Turing's board of directors since the company was founded late last year. In a statement Friday, Turing said that Tilles will continue to hold the board chairman position as well.
23:47 2 years after the hack, Sony CEO Lynton exits for Snap Inc14
18:21 Facebook CEO Mark Zuckerberg to Testify Over VR ‘Heist’ Accusations10
23:33 Sony Entertainment CEO Lynton to step down; to become Snap Inc chairman21
13:31 Panera Bread removes artificial ingredients from U.S. menu9